Is in vitro fertilisation more effective than stimulated intrauterine insemination as a first-line therapy for subfertility? A cohort analysis

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 50, Issue 3, 2010, Pages 280-288

  Chambers, Georgina M ^a   Sullivan, Elizabeth A ^a   Shanahan, Marian ^b   Ho, Maria T ^c   Priester, Katelyn ^a   Chapman, Michael G ^a,d,e  

^a Perinatal and Reproductive Epidemiology Research Unit   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e IVFAustralia   (Australia)

Author keywords

Assisted reproductive technologies; Cost effectiveness analysis; In vitro fertilisation; Infertility; Intrauterine insemination

Indexed keywords

ADULT; ARTICLE; BIRTH RATE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE INSEMINATION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; ARTIFICIAL INSEMINATION; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; INFERTILITY; MULTICENTER STUDY; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; BIRTH RATE; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; INSEMINATION, ARTIFICIAL; MALE; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 77953816596     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01155.x     Document Type: Article

References (43)

1. Gibbs RS, Danforth DN, Karlen BY, Haney AF (eds). Danforth's Obstetrics and Gynecology 10th edn.
2. National Collaborating Centre for Women's and Children's Health. Clinical Guideline 11, Fertility: Assessment and Treatment for People with Fertility Problems. Commissioned by the National Institute for Clinical Excellence (NICE). NICE 2004 London. Available at http://www.nice.org.uk.
3. Royal College of Obstetrics and Gynaecology (RCOG) Infertility Guidelines Group. The Management of Infertility in Secondary Care.
4. The Practice Committee of the American Society for Reproductive Medicine (ASRM). Effectiveness and treatment for unexplained infertility. Fertil Steril 2006 86 (Suppl 4 S211 S214.
5. Haagen EC, Hermens RPMG, Nelen WLDM, Braat DDM, Grol RPTM, Kremer JAM. Subfertility guidelines in Europe: the quantity and quality of intrauterine insemination guidelines. Hum Reprod 2006 21 (8 2103 2109.
6. Reindollar RH, Regan MM, Neumann PJ et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril (in press). doi: http://dx.doi.org/10.1016/j.fertnstert.2009.04.022.
7. Steures P, van der Steeg JW, Hompes PGA et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet 2006 368 (9531 216 221.
8. Centers for Disease Control and Prevention (CDC), American Society of Reproductive Medicine (ASRM), Society for Assisted Reproductive Technology (SART). 2006 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Available at http://www/cdc/gov/ART/ART2006.
9. Steures P, van der Steeg JW, Hompes PGA et al. Effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomized clinical trial. Fertil Steril 2007 88 (6 1692 1696.
10. The European IVF-monitoring Consortium for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 2008 23 (4 756 771.
11. Horwitz R, Viscoli C, Clemens J, Sadock R. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990 89 : 630 638.
12. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004 363 (9422 1728 1731.
13. Chambers GM, Ho MT, Sullivan EA. Assisted reproductive technology treatment costs of a live birth: an age-stratified cost-outcome study of treatment in Australia. Med J Aust 2006 184 : 155 158.
14. Chambers GM, Chapman MG, Grayson N, Shanahan M, Sullivan EA. Babies born after ART treatment cost more than non-ART babies: a cost analysis of inpatient birth-admission costs of singleton and multiple gestation pregnancies. Hum Reprod 2007 22 : 3108 3115.
15. Australian Commonwealth Government; Australian Bureau of Statistics. 6401.0 Consumer Price Index, Australia table 7. CPI: Health, Weighted Average of Eight Capital Cities. [Accessed March 2008.] Available from URL: http://www.abs.gov/Austats
16. Drummond MF, Sculpher MJ, Torrence GW, OBrien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. New York, NY, USA: Oxford University Press, 2005.
17. Glick HA, Doshi JA, Sonnard SS, Polsky D. Economic Evaluation in Clinical Trials.
18. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation.
19. Heijnen EMEW, Macklon NS, Fauser BCJM. What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment. Hum Reprod 2004 19 (9 1936 1938.
20. Wang YA, Dean JH, Badgery-Parker T, Sullivan EA. Assisted Reproduction Technology in Australia and New Zealand 2006. Assisted reproduction technology series no. 12. Cat. no. PER 43.
21. Wang YA, Chambers GM, Dieng M, Sullivan EA. Assisted Reproductive Technology in Australia and New Zealand 2007. Assisted reproduction technology series no. 13. Cat. no. PER 47.
22. Eijkemans MJC, Heijnen EMEW, de Klerk C, Habbema JDF, Fauser BCJM. Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial. Hum Reprod 2006 21 (2 344 351.
23. Tiitinen A, Hyden-Granskog C, Gissler M. What is the most relevant standard of success in assisted reproduction? The value of cryopreservation on cumulative pregnancy rates per single oocyte retrieval should not be forgotten. Hum Reprod 2004 19 (11 2439 2441.
24. Elster N. Less is more: the risks of multiple births. The Institute for Science, Law, and Technology Working Group on Reproductive Technology. Fertil Steril 2000 74 (4 617 623.
25. Fauser BCJM, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005 365 (9473 1807 1816.
26. The European Society of Human Reproduction and Embryology (ESHRE) Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod Update 2000 15 (8 1856 1864.
27. The European Society of Human Reproduction and Embryology (ESHRE) Task Force on Ethics and Law. Ethical issues related to multiple pregnancies in medically assisted procreation. Hum Reprod 2003 18 (9 1976 1979.
28. Lenton EA. Stimulated intrauterine insemination: efficient, cost-effective, safe? Hum Fertil (Camb) 2004 7 (4 253 265.
29. Custers IM, Steures P, van der Steeg JW et al. External validation of a prediction model for an ongoing pregnancy after intrauterine insemination. Fertil Steril 2007 88 (2 425 431.
30. Steures P, van der Steeg JW, Mol BWJ et al. Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril 2004 82 (1 45 51.
31. van Weert J-M, Repping S, van der Steeg JW, Steures P, van der Veen F, Mol BWJ. IUI in male subfertility: are we able to select the proper patients? Reprod Biomed Online 2005 11 (5 624 631.
32. Iberico G, Vioque J, Ariza N et al. Analysis of factors influencing pregnancy rates in homologous intrauterine insemination. Fertil Steril 2004 81 (5 1308 1313.
33. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. 5Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 1999 14 (3 698 703.
34. Stolwijk AM, Wetzels AMM, Braat DDM. Cumulative probability of achieving an ongoing pregnancy after in-vitro fertilization and intracytoplasmic sperm injection according to a woman's age, subfertility diagnosis and primary or secondary subfertility. Hum Repod 2000 15 (1 203 209.
35. Templeton A, Morris JK, Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 1996 348 (9039 1402 1406.
36. Reindollar RH, Regan MM, Alper MM, Thornton KL, Goldman MB. Are there predictive characteristics for pregnancy in couples treated for unexplained infertility? Analysis from the fast track and standard treatment (FASTT) trial. Feril Steril 2009 92 (3, Suppl 1 S252.
37. Bell CM, Urbach DR, Ray JG et al. Bias in published cost effectiveness studies: systematic review. BMJ 2006 332 : 699 703.
38. Eichler H-G, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 2004 7 : 518 528.
39. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996 312 (7040 1215 1218.
40. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet 2001 357 (9254 455 462. (Pubitemid 32156151)
41. Puffer S, Torgerson D. Recruitment difficulties in randomised controlled trails Controlled Clinical Trials. 2003 43S-240S : P241.
42. Elzeiny H, Toleda M, Stern K, McBain J, Baker G. Randomised control trial of ovarian stimulation with intrauterine insemination versus in vitro fertilisation using identical stimulation protocols. Fertility Society of Australia 26th Annual Scientific Meeting, Sydney [Abstract Aust N Z J Obstet Gynaecol 2007 47 (Suppl 1 A9.
43. Gab Kovacs G, MacLachlan V, Rombauts L, Healy D, Howlett D. Replacement of one selected embryo is just as successful as two embryo transfer, without the risk of twin pregnancy. Aust NZ J Obst Gynaecol 2003 4 : 369 371.